Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Food and Drug Administration
- Recipient company
- MIDI, INC.
- Proposal award date
- 2018-09-01
- Contract end date
- 2019-08-31
- UEI
- S9JSJFKH4BZ3
- Solicitation number
- PA17-302
- Topic code
- FDA
Research abstract
Abstract
The objective of this SBIR Phase I proposal is to test the feasibility for development of an automated platform
that can perform the followingIdentify botanical components of dietary supplements throughout the supply chain by use of chemicalanalysis and integrated pattern recognition softwareDetect the presence of adulteration by use of HPLCand UHPLCanalysis of bioactive compounds andby use of orthogonal data from other analytical instrumentse gterpene analysis by GCAutomate the quantification of the key bioactive compoundsInnovative aspects of the proposed research are the restructuring of proven MIDI Incsoftware for HPLC
analysis of bioactive components of botanical dietary supplements and use of orthogonal GC data from
metabolitessuch as terpenesThe MIDI software has been cited in more thanpublications and both the
HPLC and GC microbiology systems have FDAkclearance as medical devices for species level
identificationThusthe basic system is shown to be scientifically valid but needs modification and additions
to target botanical dietary supplementsproposed MIDI platformBotanical reference materialsBRMswill be
analyzed and the patterns stored electronicallyreducing the need for these expensive materialsChemical
analysis patterns of materials throughout the dietary supplement supply chain will also be electronically stored
to enable changes due to processing and authentication in all steps of manufacturingThe proposed technology should improve precision of compound naminglower labor costsreduce human
errorsimprove turn around time for analysisas well as meeting the objectives aboveHoweverthe keys to
success are that it should improve human health due to improvements in quality control of botanical dietary
supplementsmake it possible for the industry to largely self regulate and aid the FDA in regulation of the
industryThe result should improve human health though removal of adulterated or low quality products from
the market Narrative
In a recent Council for Responsible NutritionCRNsurveyof Americans take dietary supplementsand while most are safe and may be usefulsome are low quality and others are adulteratedThis SBIR
proposal will test the feasibility of development of an innovative platform for species level authentication of
botanical dietary supplementsdetection of adulterationand quantitation of bioactive compoundsThe
software platform will be fully automatedgive precision chemical analysis and be the basis for industry
standards aimed at improving human health
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
9 SBIR/STTR records share this UEI (1997–2018). Reported award amounts total $2,245,072. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards